blastp_kegg |
lcl|pmum:103328445
|
450 |
641 |
+ |
192 |
Gaps:2 |
64.45 |
301 |
88.14 |
3e-108 |
26S proteasome non-ATPase regulatory subunit 2 homolog A-like
|
blastp_kegg |
lcl|cam:101498643
|
450 |
641 |
+ |
192 |
Gaps:2 |
21.90 |
886 |
89.18 |
6e-105 |
26S proteasome non-ATPase regulatory subunit 2 1A-like
|
blastp_kegg |
lcl|tcc:TCM_008190
|
450 |
641 |
+ |
192 |
Gaps:2 |
21.92 |
885 |
90.72 |
7e-105 |
26S proteasome regulatory subunit S2 1A isoform 1
|
blastp_kegg |
lcl|mtr:MTR_4g078780
|
450 |
641 |
+ |
192 |
Gaps:2 |
21.90 |
886 |
89.69 |
2e-104 |
26S proteasome non-ATPase regulatory subunit
|
blastp_kegg |
lcl|csv:101206940
|
450 |
641 |
+ |
192 |
Gaps:2 |
21.65 |
896 |
87.63 |
6e-104 |
26S proteasome non-ATPase regulatory subunit 2 1A-like
|
blastp_kegg |
lcl|cmo:103495645
|
450 |
641 |
+ |
192 |
Gaps:2 |
21.65 |
896 |
87.63 |
1e-103 |
26S proteasome non-ATPase regulatory subunit 2 homolog A
|
blastp_kegg |
lcl|vvi:100255701
|
450 |
641 |
+ |
192 |
Gaps:2 |
21.80 |
890 |
88.66 |
2e-103 |
26S proteasome regulatory subunit N1-like
|
blastp_kegg |
lcl|mdm:103444431
|
450 |
641 |
+ |
192 |
Gaps:2 |
21.70 |
894 |
88.14 |
2e-102 |
26S proteasome non-ATPase regulatory subunit 2 homolog A
|
blastp_kegg |
lcl|gmx:100777078
|
450 |
641 |
+ |
192 |
Gaps:2 |
21.92 |
885 |
88.14 |
9e-102 |
26S proteasome non-ATPase regulatory subunit 2 homolog A-like
|
blastp_kegg |
lcl|fve:101302279
|
452 |
642 |
+ |
191 |
Gaps:2 |
21.64 |
892 |
86.53 |
2e-101 |
26S proteasome non-ATPase regulatory subunit 2 1A-like
|
blastp_pdb |
2w3c_A
|
315 |
382 |
+ |
68 |
none |
11.79 |
577 |
47.06 |
5e-09 |
mol:protein length:577 GENERAL VESICULAR TRANSPORT FACTOR P115
|
blastp_pdb |
3grl_A
|
315 |
382 |
+ |
68 |
none |
10.45 |
651 |
47.06 |
5e-09 |
mol:protein length:651 General vesicular transport factor p115
|
blastp_pdb |
3gq2_B
|
315 |
382 |
+ |
68 |
none |
10.45 |
651 |
47.06 |
5e-09 |
mol:protein length:651 General vesicular transport factor p115
|
blastp_pdb |
3gq2_A
|
315 |
382 |
+ |
68 |
none |
10.45 |
651 |
47.06 |
5e-09 |
mol:protein length:651 General vesicular transport factor p115
|
blastp_pdb |
3eiq_C
|
670 |
794 |
+ |
125 |
Gaps:2 |
34.92 |
358 |
30.40 |
7e-06 |
mol:protein length:358 Programmed cell death protein 4
|
blastp_uniprot_sprot |
sp|Q9SIV2|PSD2A_ARATH
|
450 |
641 |
+ |
192 |
Gaps:2 |
21.77 |
891 |
82.47 |
1e-96 |
26S proteasome non-ATPase regulatory subunit 2 homolog A OS Arabidopsis thaliana GN RPN1A PE 1 SV 2
|
blastp_uniprot_sprot |
sp|Q6XJG8|PSD2B_ARATH
|
450 |
641 |
+ |
192 |
Gaps:2 |
21.77 |
891 |
78.35 |
8e-90 |
26S proteasome non-ATPase regulatory subunit 2 homolog B OS Arabidopsis thaliana GN RPN1B PE 1 SV 1
|
blastp_uniprot_sprot |
sp|Q13200|PSMD2_HUMAN
|
450 |
638 |
+ |
189 |
Gaps:5 |
20.93 |
908 |
54.74 |
1e-52 |
26S proteasome non-ATPase regulatory subunit 2 OS Homo sapiens GN PSMD2 PE 1 SV 3
|
blastp_uniprot_sprot |
sp|Q5R9I6|PSMD2_PONAB
|
450 |
638 |
+ |
189 |
Gaps:5 |
20.93 |
908 |
54.21 |
2e-52 |
26S proteasome non-ATPase regulatory subunit 2 OS Pongo abelii GN PSMD2 PE 2 SV 1
|
blastp_uniprot_sprot |
sp|P56701|PSMD2_BOVIN
|
450 |
638 |
+ |
189 |
Gaps:5 |
20.93 |
908 |
54.21 |
4e-52 |
26S proteasome non-ATPase regulatory subunit 2 OS Bos taurus GN PSMD2 PE 1 SV 2
|
blastp_uniprot_sprot |
sp|Q4FZT9|PSMD2_RAT
|
450 |
638 |
+ |
189 |
Gaps:5 |
20.93 |
908 |
54.21 |
1e-51 |
26S proteasome non-ATPase regulatory subunit 2 OS Rattus norvegicus GN Psmd2 PE 2 SV 1
|
blastp_uniprot_sprot |
sp|Q8VDM4|PSMD2_MOUSE
|
450 |
638 |
+ |
189 |
Gaps:5 |
20.93 |
908 |
54.21 |
1e-51 |
26S proteasome non-ATPase regulatory subunit 2 OS Mus musculus GN Psmd2 PE 1 SV 1
|
blastp_uniprot_sprot |
sp|P87048|RPN1_SCHPO
|
450 |
642 |
+ |
193 |
Gaps:2 |
21.89 |
891 |
52.31 |
1e-48 |
26S proteasome regulatory subunit rpn1 OS Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN rpn1 PE 1 SV 2
|
blastp_uniprot_sprot |
sp|Q54BC6|PSMD2_DICDI
|
450 |
636 |
+ |
187 |
Gaps:3 |
21.05 |
893 |
53.19 |
4e-48 |
26S proteasome non-ATPase regulatory subunit 2 OS Dictyostelium discoideum GN psmD2 PE 1 SV 1
|
blastp_uniprot_sprot |
sp|B0F9L4|GOGC6_ARATH
|
331 |
449 |
+ |
119 |
Gaps:17 |
14.88 |
914 |
69.85 |
6e-47 |
Golgin candidate 6 OS Arabidopsis thaliana GN GC6 PE 1 SV 2
|
rpsblast_cdd |
gnl|CDD|34713
|
450 |
638 |
+ |
189 |
Gaps:3 |
21.79 |
881 |
47.40 |
2e-51 |
COG5110 RPN1 26S proteasome regulatory complex component [Posttranslational modification protein turnover chaperones].
|
rpsblast_cdd |
gnl|CDD|111714
|
714 |
794 |
+ |
81 |
Gaps:1 |
72.57 |
113 |
35.37 |
1e-14 |
pfam02847 MA3 MA3 domain. Domain in DAP-5 eIF4G MA-3 and other proteins. Highly alpha-helical. May contain repeats and/or regions similar to MIF4G domains.
|
rpsblast_cdd |
gnl|CDD|128817
|
714 |
794 |
+ |
81 |
Gaps:1 |
72.57 |
113 |
35.37 |
3e-13 |
smart00544 MA3 Domain in DAP-5 eIF4G MA-3 and other proteins. Highly alpha-helical. May contain repeats and/or regions similar to MIF4G domains Ponting (TIBS) "Novel eIF4G domain homologues" in press.
|
rpsblast_cdd |
gnl|CDD|165506
|
130 |
333 |
+ |
204 |
Gaps:14 |
6.60 |
3151 |
19.23 |
2e-08 |
PHA03247 PHA03247 large tegument protein UL36 Provisional.
|
rpsblast_cdd |
gnl|CDD|146000
|
130 |
305 |
+ |
176 |
Gaps:13 |
19.31 |
979 |
21.69 |
6e-08 |
pfam03154 Atrophin-1 Atrophin-1 family. Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1 that is thought to confer toxicity to the protein possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity.
|